Evotec Announces Executive Transition in CFO Role

Evotec SE, a global life sciences company, has announced a significant change in its Management Board. Chief Financial Officer Laetitia Rouxel will step down from her role on February 28, 2025. Rouxel leaves to pursue new opportunities after joining the company in April 2023.

Paul Hitchin will succeed Rouxel as CFO, starting March 1, 2025. With over 20 years of experience in finance leadership, Hitchin was formerly CFO at Mediq. His expertise in finance and transformation will aid Evotec in its journey towards sustainable growth.

Prof. Dr. Iris Löw-Friedrich, Chairwoman of the Supervisory Board, expressed gratitude for Rouxel's contributions during challenging times. She also welcomed Hitchin, emphasizing his role in Evotec's future growth.

This transition underscores Evotec's strategic focus on enhancing its financial strategies as it aims for profitable progress.